期刊文献+

三阴性乳腺癌外周血及病灶微环境辅助性和调节性T细胞表达 被引量:5

Auxiliary and Regulatory T cells Expression in Peripheral Blood and Lesion Microenvironment of Patients with Triple-negative Breast Cancer
下载PDF
导出
摘要 目的分析三阴性乳腺癌(trip nenegative breast cancer,TNBC)患者外周血及病灶微环境辅助性T细胞和调节性T细胞的表达水平。方法选择2012年1—4月经临床及病理确诊的女性TNBC 34例(TNBC组)、非三阴性乳腺癌(NTNBC)39例(NTNBC组)及同期确诊为乳腺良性疾病女性患者27例(对照组),均检测外周血及病灶微环境辅助性T细胞(CD3+、CD4+、CD8+、CD4+/CD8+)和调节性T细胞(CD4CD25+Treg和CD4+CD25+Foxp3+Treg),并进行比较。结果 TNBC组外周血及病灶微环境CD3+、CD4+水平、CD4+/CD8+比值均明显低于NTNBC及对照组,而CD8+水平则明显高于其他两组(P<0.05);TNBC组外周血及病灶微环境CD4CD25+Treg及CD4+CD25+Foxp3+Treg表达水平均明显高于NTNBC组及对照组(P<0.05)。结论 TNBC患者存在明确的外周血及病灶微环境调节性T细胞和辅助性T细胞异常表达,其可作为本病免疫学病因诊断及评估疗效的特征性标识,并为今后寻找TNBC免疫治疗途径提供试验数据。 Objective To analyze the levels of the auxiliary and regulatory T cells expression in peripheral blood and lesion microenvironment of patients with triple-negative breast cancer( TNBC). Methods The levels of auxiliary T cells( CD3^+,CD4^+,CD8^+,CD4^+/CD8^+) and regulatory T cells( CD4CD25^+ Treg and CD4^+CD25^+Foxp3^+Treg) in peripheral blood and lesion microenvironment were detected for 34 TNBC patients( TNBC group) confirmed by clinical and pathological results,39 non-TNBC patients( NTNBC group) and 27 patients with benign breast diseases( control group) from 2012January to April,and the levels in the three groups were also compared. Results In the TNBC group,the levels of CD3^+,CD4^+ and CD4^+/CD8^+ were significantly lower than those in the NTNBC and control groups,but the CD8+ level was significantly higher than that in the NTNBC and control groups( P 〈0. 05); the levels of CD4CD25+Treg and CD4+CD25+Foxp3+Treg in the TNBC group were significantly higher than those in the NTNBC and control groups( P 〈0. 05). Conclusion The auxiliary and regulatory T cells are abnormally expressed in the peripheral blood and lesion microenvironment in TNBC patients,which is a characteristic parameter of immunology in etiological diagnosis and evaluation effect,wihich may provide test data to find a method of TNBC immunotherapy in the future.
出处 《临床误诊误治》 2014年第6期67-70,共4页 Clinical Misdiagnosis & Mistherapy
基金 2010年辽宁省自然科学基金资助项目(20102119)
关键词 乳腺肿瘤 T淋巴细胞 调节性 T淋巴细胞 辅助诱导 血液 肿瘤微环境 Breast neoplasm T-Lymphocyte regulatory T-lymphocyte helper-inducer Blood Tumor microenvironment
  • 相关文献

参考文献10

  • 1Nair S, Aldrich A J, McDonnell E, et al. Immunologictargeting of FOXP3 in inflammatory breast cancer cells [J]. PLoS One, 2013,8(1) :e53150. 被引量:1
  • 2顾军,于泽平,李宁.三阴性乳腺癌的研究进展[J].医学研究生学报,2010,23(1):105-109. 被引量:27
  • 3Stagg J, Allard B. lmmunotherapeutic approaches in triple- negative breast cancer: latest research and clinical prospects [J]. Ther Adv Med Oncol, 2013,5(3) :169-181. 被引量:1
  • 4林华燕,吴平,何惠娟,杨展.乳腺癌患者外周血Th1/Th2细胞因子的漂移及其与病理和临床病程的关系[J].肿瘤研究与临床,2006,18(5):304-306. 被引量:12
  • 5Nishimura T. The regulation of antitumor immune respon- ses by helper T cells-From the bench research to the dis- covery of H/K-HELP cancer vaccine [ J ]. Nihon Rinsho Meneki Gakkai Kaishi, 2012,35(5) :412-423. 被引量:1
  • 6West N R, Kost S E, Martin S D, et al. Tumour-infihra- ting FOXP3 ( + ) lymphocytes are associated with cytotox- ic immune responses and good clinical outcome in oestro- gen receptor-negative breast cancer [ J]. Br J Cancer, 2013,108( 1 ) :155-162. 被引量:1
  • 7Decker T, Fischer G, Bilcke W, et al. Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive earlybreast cancer[ J]. J Cancer Res Clin Oncol, 2012,138( 11 ) :1945-1950. 被引量:1
  • 8Cimino-Mathews A, Ye X, Meeker A, et al. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study[ J]. Hum Pathol, 2013,44 (10) :2055-2063. 被引量:1
  • 9Bates G J, Fox S B, Han C, et al. Quantification of reg- ulatory T ceils enables the identification of high-risk breast cancer patients and those at risk of late relapse [ J ]. J Clin Oncol, 2006,24 ( 34 ) : 5373 -5380. 被引量:1
  • 10严丽,李清怀,李莉,蔡建辉.乳腺癌微环境中调节性T细胞表达及其意义研究[J].中国实用外科杂志,2011,31(5):447-449. 被引量:5

二级参考文献18

  • 1Sebastian T, Bing-Mae C, Ying L, et al. Combination of Tumor Site-Located CTL-Associated Antigen-4 Blockade and Systemic Regulatory T-Cell Depletion Induces Tumor-Destructive Immune Responses [J]. Cancer Res, 2007,67 (12):5929-5939. 被引量:1
  • 2Knutson KL, Dang Y, Lu H, et al. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice[J]. J Immunol, 2006, 177(1): 84-91. 被引量:1
  • 3Andrew G, Joanne L, Stephen T, et al Suppression of Antitumor Immunity by IL-10 and TGF Producing T Cells Infiltrating the Growing Tumor: Influence of Tumor Environment on the Induction of CD4_ and CD8_ Regulatory T Cells [J]. J Immnunol, 2006, 177(9):896-904. 被引量:1
  • 4Ren Z,Pang G,Clancy R,et al.Shift of the gastric T-cell response in gastric carcinoma[J].J Gastroenterol Hepatol,2001,16(2):142-148. 被引量:1
  • 5Aniszewski J P,Valyasevi R W,Bahn R S.Relationship between duration and predominant orbital T cell subset in Graves' ophthamopathy[J].Clin Endocrinol Metab,2000,85(2):776-780. 被引量:1
  • 6Mosmann T R,Cherwinski H,Bond M W,et al.Two types of murine helper T cell clone I Definition according to profiles of lymphokine activities and secreted proteins[J].J Immunol,1986,136(7):2348-2357. 被引量:1
  • 7Yamamura M,Modlin R L,Ohmen J D,et al.Local expression of antiinflammatory cytokines in cancer[J].Clin Invest,1993,91(3):1005-1010. 被引量:1
  • 8Kharkevitch D D,Seito D,Balch G C,et al.Characterization of autologous tumor-specific T-helper 2 cells in tumor infiltrating lymphocytes from a patient with metastatic melanoma[J].Int J cancer,1994,58(3):317-323. 被引量:1
  • 9Romagnani S.Human Th1 and Th2 subsets no more[J].Immunol Today,1991,12(8):256-257. 被引量:1
  • 10Lu J,Philpott D J,Saunders P R,et al.Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cell are inhibited by interleukin-10 but not interleukin-4[J].J Pharmacol Exp Ther,1998,287(1):128-136. 被引量:1

共引文献41

同被引文献91

  • 1刘璇,郝敬全,温少瑾.调节性T细胞在肿瘤免疫和肿瘤免疫治疗中的作用[J].医学信息(医学与计算机应用),2014,0(13):491-491. 被引量:1
  • 2马树东,罗荣城,丁彦青,刘来煜,蔡俊杰.乳腺癌组织中EGFR、IGF-1R、HER2/neu和p53蛋白的表达及意义[J].肿瘤防治杂志,2005,12(5):335-338. 被引量:12
  • 3Sawada Y, Fu]// T, Takahashi H, et al. A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy) [J]. Gan To Kagaku Ryoho, 2009,36(5) :815-817. 被引量:1
  • 4Hachisuka Y, Kamei Y, Umeoka T, et al. A case of triple negative recurrent breast cancer successfully treated with capecitabine + docetaxel combination chemotherapy [J]. Gan To Kagaku Ryoho, 2008,35 (3) :475-478. 被引量:1
  • 5Bernsdorf M, Ingvar C, Jorgensen L, et at. Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase IT trial [J]. Breast Cancer Res Treat, 2011, 126 (2) :463-470. 被引量:1
  • 6Iwata H, Sato N, Masuda N, et al. Docetaxel followed by fluorouracil! epirubicinl cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer] J J . Jpn J Clin Oncol, 2011 ,41(7) :867-875. 被引量:1
  • 7Kwast A B, Liu L, Roukema J A, et al. Increased risks of third primary cancers of non-breast orrgin among women with bilateral breast cancer [J]. Br J Cancer, 2012,107 (3) :549-555. 被引量:1
  • 8Susan Cleator,Wolfgang Heller,R Charles Coombes.Triple-negative breast cancer: therapeutic options[J]. Lancet Oncology . 2007 (3) 被引量:2
  • 9Emad A.Rakha,Maysa E.El‐Sayed,Andrew R.Green,Andrew H. S.Lee,John F.Robertson,Ian O.Ellis.Prognostic markers in triple‐negative breast cancer[J]. Cancer . 2006 (1) 被引量:4
  • 10Kalliopi P. Siziopikou,Melody Cobleigh.The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies[J]. The Breast . 2006 (1) 被引量:2

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部